本页面由Tiger Trade Technology Pte. Ltd.提供服务

Artelo Biosciences, Inc.

2.98
-0.1300-4.18%
盘后:3.080.1000+3.36%16:11 EDT
成交量:3.07万
成交额:9.24万
市值:163.24万
市盈率:-0.03
高:3.12
开:3.11
低:2.92
收:3.11
52周最高:179.19
52周最低:2.92
股本:54.78万
流通股本:54.74万
量比:0.69
换手率:5.61%
股息:- -
股息率:- -
每股收益(TTM):-102.4151
每股收益(LYR):-337.9329
净资产收益率:-705.71%
总资产收益率:-127.92%
市净率:0.33
市盈率(LYR):-0.01

数据加载中...

2025/05/01

重要事件披露

Form 8-K - Current report
2025/04/29

重要事件披露

Form 8-K - Current report
2025/03/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/03

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/12/20

重要事件披露

Form 8-K - Current report
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/17

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2024/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/04

重要事件披露

Form 8-K - Current report
2023/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report
2023/07/12

SEC问询函

Form CORRESP - Correspondence
2023/07/04

重要事件披露

Form 8-K - Current report
2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/21

重要事件披露

8-K - Current report
2023/04/21

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans